Timeline essential: Lethargic Kuehne + Nagel? 'Just take it private'
And what the market doesn’t want
ID 5328998 © Nikolai Sorokin | Dreamstime.com
REUTERS reports:
Private equity firm Carlyle Group Inc (CG.O) has entered into exclusive negotiations to acquire a majority stake in two medical device businesses of Medtronic Plc at a valuation of more than $7 billion, according to people familiar with the matter.
Were an agreement to be reached in the coming weeks, it would mark the culmination of Medtronic’s 12-month review of its patient monitoring and respiratory interventions businesses, that it also considered spinning off. Medtronic is seeking to streamline its portfolio and focus on its higher-growth assets, such as its heart and diabetes devices…
To read the full post, please click here.
Comment on this article